Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Enanta Pharmaceuticals, Inc. | StockGist | StockGist

Companies
ENTA
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings ENTASCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Enanta Pharmaceuticals, Inc.

Filed Nov 7, 2025

Accepted Nov 6, 2025, 7:00 PM ET

CIK 0001177648

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

ENANTA PHARMACEUTICALS INC

Person Type

IA

CUSIP: 29251M106

Amendment History

7 filings

SCHEDULE 13G
Original
Viewing
Nov 7, 20250001274173-25-000261
SCHEDULE 13G/A
Amendment 1
Feb 11, 20250000908834-25-000061
SCHEDULE 13G/A
Amendment 2
Apr 17, 20250001576419-25-000590
SCHEDULE 13G/A
Amendment 3
Nov 13, 20250001104659-25-111375
SCHEDULE 13G/A
Amendment 4
Jan 20, 20260001104659-26-005096
SCHEDULE 13G/A
Amendment 5
Feb 13, 20260001172661-26-000711
SCHEDULE 13G/A
Amendment 6
Latest
Mar 26, 20260000102909-26-001192

Recent Filings

Enanta Pharmaceuticals, Inc.1 weeks ago

Enanta Pharmaceuticals, Inc.1 weeks ago

Enanta Pharmaceuticals, Inc.3 weeks ago

Enanta Pharmaceuticals, Inc.1 months ago

Enanta Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice